Colonic absorptive epithelial cell

Viable absorptive epithelial cells of the colonic mucosa, commonly referred to as colonocytes, are the primary cell type responsible for the final stages of water and electrolyte absorption in the human digestive tract [1]. These cells utilize specialized transporters to absorb sodium and chloride, while also facilitating the uptake of short-chain fatty acids (SCFAs) like butyrate, which provide the majority of the metabolic energy required by the colonic epithelium [2]. Beyond their absorptive capacity, they form a critical physical and biochemical barrier, utilizing tight junction proteins and secreting antimicrobial peptides to prevent the translocation of luminal bacteria into the underlying tissue [3]. In pathological states such as ulcerative colitis or Crohn's disease, the loss of these cells or the disruption of their barrier function leads to inflammation, ulceration, and severe diarrhea [3]. While the cell itself is a biological entity rather than a single molecular target, it expresses key proteins like guanylate cyclase-C (GC-C) and chloride channels (e.g., ClC-2), which are the specific molecular targets for drugs like linaclotide and lubiprostone used to treat chronic constipation and irritable bowel syndrome [4][5]. These cells are also the site of action for locally acting anti-inflammatory agents like mesalamine, which help maintain mucosal integrity in inflammatory bowel disease [3].

Other names

ColonocyteAbsorptive cell of the large intestineColonic epithelial cellViable absorptive epithelial cells of the colonic mucosa

Activation of guanylate cyclase-C, activation of chloride channels (ClC-2), local anti-inflammatory effects, and glucocorticoid receptor agonism.